StockData
Accustem Sciences Inc. logo

Accustem Sciences Inc. (ACUT) income statement

ACUTOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 20, 2026Score 4/30
$0.15+0.00 (0.00%)

Close on Oct 16, 2026Market cap $2.37MP/E –Yield –

See a number that looks wrong?